Abstract
Methods
Results
Conclusions
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The Journal of Heart and Lung TransplantationReferences
Olivari MT, Jessen ME, Baldwin BJ, et al. Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation. J Heart Lung Transplant 1995;14(1 Pt 1):127–35.
Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987;76(4):827–34.
Gao SZ, Schroeder JS, Alderman EL, et al. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens. Circulation 1989;80(5 Pt 2):III100–5.
Hosenpud JD, Everett JP, Morris TE, et al. Cellular and humoral immunity to vascular endothelium and the development of cardiac allograft vasculopathy. JHeart Lung Transplant 1995;14(6 Pt 2):S185–7.
Hosenpud JD, Everett JP, Morris TE, et al. Cardiac allograft vasculopathy. Association with cell-mediated but not humoral alloimmunity to donor-specific vascular endothelium. Circulation 1995;92(2):205–11.
Ardehali A, Drinkwater DC, Jr., Laks H, Drake TA. Cardiac allograft vasculopathy, editorial. American Heart Journal 1993;126(6):1498–502.
Labarrere CA, Pitts D, Nelson DR, Faulk WP. Coronary artery disease in cardiac allografts: association with depleted arteriolar tissue plasminogen activator. Transplant Proc 1995;27(3):1941–3.
- Hemostasis, fibrinolysis, and natural anticoagulation in transplant vascular sclerosis.J Heart Lung Transplant. 1995; 14: s158-s164
Labarrere CA, Pitts D, Nelson DR, Faulk WP. Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients. N Engl J Med 1995;333(17):1111–6.
Yeung AC, Davis SF, Hauptman PJ, et al. Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. Multicenter Intravascular Ultrasound Transplant Study Group. J Heart Lung Transplant 1995;14(6 Pt 2):S215–20.
Lee J, Laks H, Drinkwater DC, et al. Cardiac gene transfer by intracoronary infusion of adenovirus vector-mediated reporter gene in the transplanted mouse heart. J Thorac Cardiovasc Surg 1996;111(1):246–52.
Dalesandro J, Akimoto H, Gorman CM, et al. Gene therapy for donor hearts: ex vivo liposome-mediated transfection. J Thorac Cardiovasc Surg 1996;111(2):416–21; discussion 421–2.
- Intracoronary gene transfer of immunosuppressive cytokines to cardiac allografts.J Thorac Cardiovasc Surg. 1997; 113: 1059-1067
Stephan DJ, Yang ZY, San H, et al. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum Gene Ther 1996;7(15):1803–12.
Wheeler CJ, Felgner PL, Tsai YJ, et al. A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung. Proc Natl Acad Sci USA 1996;93(21):11454–9.
Sedmak DD, Orosz CG. The role of vascular endothelial cells in transplantation. Arch Pathol Lab Med 1991;115(3):260–5.
Ardehali A, Laks H, Drinkwater DC, et al. Vascular cell adhesion molecule-1 is induced on vascular endothelia and medial smooth muscle cells in experimental cardiac allograft vasculopathy. Circulation 1995;92(3):450–6.
Poston RS, Jr, Billingham ME, Pollard J, Hoyt EG. Effects of increased ICAM-1 on reperfusion injury and chronic graft vascular. Ann Thorac Surg 1997;64(4):1004–12.
Dichek DA, Anderson J, Kelly AB, et al. Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. Circulation 1996;93(2):301–9.
